Long-term efficacy of oral deferiprone in management of iron overload in beta thalassemia major

Author： Goel Himanshu   Girisha K. M.   Phadke Shubha R.  

Publisher： Maney Publishing

ISSN： 1024-5332

Source： Hematology, Vol.13, Iss.2, 2008-04, pp. : 77-82

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Iron-chelation therapy with oral chelators in patients with thalassemia major

By Uygun Vedat  

Hematology, Vol. 18, Iss. 1, 2013-01 ,pp. : 50-55

Maney Publishing

Access to resources Recommend Favorite

Effectiveness of deferiprone in transfusion-independent beta-thalassemia/HbE patients

By Akrawinthawong Krittapoom   Chaowalit Nithima   Chatuparisuth Thanasaporn   Siritanaratkul Noppadol  

Hematology, Vol. 16, Iss. 2, 2011-03 ,pp. : 113-122

Maney Publishing

Access to resources Recommend Favorite

Deferiprone versus Deferoxamine in Patients with Thalassemia Major: A Randomized Clinical Trial

By Maggio A.   D'Amico G.   Morabito A.   Capra M.   Ciaccio C.   Cianciulli P.   Di Gregorio F.   Garozzo G.   Malizia R.   Magnano C.   Mangiagli A.   Quarta G.   Rizzo M.   D'Ascola D.G.   Rizzo A.   Midiri M.  

Blood Cells, Molecules, and Diseases, Vol. 28, Iss. 2, 2002-02 ,pp. : 196-208

Academic Press

Access to resources Recommend Favorite

Transfusional iron overload and chelation therapy with deferoxamine and deferiprone (L1)

By Kontoghiorghes G.J.   Pattichi K.   Hadjigavriel M.   Kolnagou A.  

Transfusion and Apheresis Science, Vol. 23, Iss. 3, 2000-12 ,pp. : 211-223

Elsevier

Access to resources Recommend Favorite

Transfusional iron overload and chelation therapy with deferoxamine and deferiprone (L1)

By Kontoghiorghes G.J.   Pattichi K.   Hadjigavriel M.   Kolnagou A.  

Transfusion Science, Vol. 23, Iss. 3, 2000-12 ,pp. : 211-223

Elsevier

Access to resources Recommend Favorite